Hersh Singh, Krish Vasudev, Jeffery Garland and Kawaljeet Kaur*
Objective: Assess the impact of the COVID-19 pandemic on a cohort of diabetic patients by comparing glycated hemoglobin (A1C) values and body mass index (BMI) before and a year into the pandemic.
Methods: Retrospective chart review (275 charts) from a single endocrinology practice. Paired t-tests were used for data analysis.
Results: A1C values improved one year into the pandemic as compared to right before the pandemic (P<0.009). Improvement was primarily seen in patient age group ≤ 60 (P= 0.008) and in those with inadequate glycemic control at baseline (initial A1C ≥7) (P=0.0001). Improvement was seen in both males and females. Change in BMI was not significant.
Conclusion: Overall, glycemic control showed improvement during the lockdown related to COVID-19 pandemic.
